| Schedule of Revenue by Different Product Lines |
The total revenue by different product
lines was as follows:
| |
|
Three months ended |
|
|
Nine months ended |
|
| |
|
September 30, |
|
|
September 30, |
|
| Product Line |
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
| |
|
|
|
|
|
|
|
(restated) |
|
|
|
|
| MicroParticle Catalyzed Biosensor (“MPC”) |
|
$ |
104,094 |
|
|
$ |
85,337 |
|
|
$ |
259,601 |
|
|
$ |
195,040 |
|
| Particle ImmunoFiltration Assay (“PIFA”) |
|
|
490,058 |
|
|
|
514,840 |
|
|
|
1,477,726 |
|
|
|
2,029,095 |
|
| Rapid Enzymatic Assay (“REA”) |
|
|
27,500 |
|
|
|
- |
|
|
|
27,500 |
|
|
|
- |
|
| Other |
|
|
16,679 |
|
|
|
13,021 |
|
|
|
613,614 |
|
|
|
83,573 |
|
| Product Revenue Total |
|
$ |
638,331 |
|
|
$ |
613,198 |
|
|
$ |
2,378,441 |
|
|
$ |
2,307,708 |
|
| License Fees |
|
|
37,500 |
|
|
|
- |
|
|
|
37,500 |
|
|
|
- |
|
| Total Revenue |
|
$ |
675,831 |
|
|
$ |
613,198 |
|
|
$ |
2,415,941 |
|
|
$ |
2,307,708 |
|
|
| Schedule of Revenue by Geographic Area Determined Based on the Location of the Customers |
The total revenue by geographic area
determined based on the location of the customers was as follows:
| |
|
Three months ended |
|
|
Nine months ended |
|
| |
|
September 30, |
|
|
September 30, |
|
| Geographic Region |
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
| |
|
|
|
|
|
|
|
(restated) |
|
|
|
|
| United States |
|
$ |
626,077 |
|
|
$ |
603,006 |
|
|
$ |
1,755,558 |
|
|
$ |
1,721,967 |
|
| People’s Republic of China |
|
|
- |
|
|
|
383 |
|
|
|
502,268 |
|
|
|
506,781 |
|
| Rest of World |
|
|
49,754 |
|
|
|
9,809 |
|
|
|
158,115 |
|
|
|
78,960 |
|
| Total Revenue |
|
$ |
675,831 |
|
|
$ |
613,198 |
|
|
$ |
2,415,941 |
|
|
$ |
2,307,708 |
|
|